MapLight Therapeutics, Inc.
NASDAQ:MPLTBiotechnology
Healthcare
$6.65 +3.11%
+$0.39 today
- Market cap
- $283.41M
- Beta
- 2.65
- P/E (TTM)
- -2.8
- EPS (TTM)
- -$4.41
52W Low $9.10High $40.43
Volume 0.42M
Average 0.73M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$169.08M
FY 2025 · Annual
Net Income
-$161.15M
FY 2025 · Annual
Income Statement
USD
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 574K | 556K | 701K | 578K |
| Gross Profit | (574K) | (556K) | (701K) | (578K) |
| Gross Margin | — | — | — | — |
| Research & Development | 26.57M | 49.12M | 67.82M | 137.77M |
| Selling, General & Admin | 4.1M | 7.61M | 14.42M | 30.73M |
| Operating Expenses | 30.67M | 56.73M | 82.25M | 168.51M |
| Depreciation & Amortization | 574K | 556K | 701K | 578K |
| EBITDA | (29.44M) | (55.15M) | (76.88M) | (160.57M) |
| EBITDA Margin | — | — | — | — |
| Operating Income | (31.25M) | (57.28M) | (82.95M) | (169.08M) |
| Operating Margin | — | — | — | — |
| Interest Income | 429K | 1.1M | 4.5M | 5.52M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.23M | 1.57M | 5.37M | 7.93M |
| Income Before Tax | (30.02M) | (55.71M) | (77.58M) | (161.15M) |
| Pre-Tax Margin | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (30.02M) | (55.71M) | (77.58M) | (161.15M) |
| Net Margin | — | — | — | — |
| EPS (Basic) | (0.72) | (1.34) | (1.87) | (3.66) |
| EPS (Diluted) | (0.72) | (1.34) | (1.87) | (3.66) |
| 41.43M | 41.43M | 41.43M | 44.02M | |
| 41.43M | 41.43M | 41.43M | 44.02M |
MPLT Earnings Waterfall · TTM
NASDAQ:MPLT · Revenue to Net Income
Key Ratios
EPS$-4.58
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.8
P/S Ratio0.0
Analysis
$0 of revenue converted into -$199.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-4.58, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 |
How much revenue does MPLT generate?
MapLight Therapeutics, Inc. (MPLT) reported $0.00 of revenue in fiscal 2025.
Is MPLT profitable?
MapLight Therapeutics, Inc. (MPLT) reported -$161.15M of net income.
Continue the stock analysis
Jump to another research area for this company.